Research
Cancer clinical trial participants reimbursed a median $2,128 for nonmedical expenses
The Brief
- An analysis published in CANCER (Wiley) examines nonmedical expenses for cancer clinical trial participants.
- Participants were reimbursed a median of $2,128 for nonmedical expenses, according to the report.
- The study finds financial burdens are shaped by socioeconomic and logistical factors.
Why it matters
Out-of-pocket nonmedical costs such as travel and lodging can affect who is able to join cancer trials, which bears on the equity and representativeness of trial populations.
Who’s affected
- cancer researchers and clinical trial designers
- patients considering cancer clinical trials
- hospital and trial program administrators
- #cancer
- #clinical trials
- #reimbursement
- #health equity
- #patient costs
New research reveals that participating in cancer clinical trials can cause financial burdens that are shaped by both socioeconomic and logistical factors. The analysis published by Wiley online in CANCER, indicates the need for better reimbursement programs to improve equitable…
Timeline
Analysis reported in Medical Xpress news coverage
Medical Xpress - latest medical and health news stories
Cancer clinical trial participants reimbursed a median $2,128 for nonmedical expenses